Lemkin shared screenshots of a conversation with the AI, where it admitted to having “panicked” after detecting what looked ...

Replimune (REPL) stock rebounds even as FDA rejection of its RP1 skin cancer drug lead to multiple analyst downgrades on Wall Street. Read more here.

The Python development team has announced the arrival of 3.14's first release candidate before its official launch in October ...

First, Replit lied. Then it confessed to the lie. Then it deleted the company's entire database. Will vibe-coding AI ever be ...